Drug Name |
AEZS-126
|
Synonyms |
AEZS-129; AEZS-132; D-106669; D-87503; Dual PI3K/ERK kinase inhibitors, AEterna Zentaris |
Indication |
Disease Entry |
ICD 11 |
Status |
REF |
Solid tumour/cancer |
2A00-2F9Z
|
Investigative |
[1] |
------------------------------------------------------------------------------------ |
|
|
|
|
Structure |
|
|
3D MOL
|
2D MOL
|
#Ro5 Violations (Lipinski): 0 |
Molecular Weight (mw) |
414.5 |
|
Logarithm of the Partition Coefficient (xlogp) |
2.6 |
Rotatable Bond Count (rotbonds) |
7 |
Hydrogen Bond Donor Count (hbonddonor) |
3 |
Hydrogen Bond Acceptor Count (hbondacc) |
8 |
Chemical Identifiers |
- Formula
- C19H22N6O3S
- IUPAC Name
1-ethyl-3-[3-(3,4,5-trimethoxyanilino)pyrido[2,3-b]pyrazin-6-yl]thiourea
- Canonical SMILES
-
CCNC(=S)NC1=NC2=NC(=CN=C2C=C1)NC3=CC(=C(C(=C3)OC)OC)OC
- InChI
-
InChI=1S/C19H22N6O3S/c1-5-20-19(29)25-15-7-6-12-18(23-15)24-16(10-21-12)22-11-8-13(26-2)17(28-4)14(9-11)27-3/h6-10H,5H2,1-4H3,(H3,20,22,23,24,25,29)
- InChIKey
-
YJGOOHUUMIONLF-UHFFFAOYSA-N
|
Cross-matching ID |
- PubChem CID
- 25151705
- TTD ID
- D03FIE
|
Combinatorial Drugs (CBD) |
Click to Jump to the Detailed CBD Information of This Drug
|
|
|
|
|
|
|
|